Skip to content

VCEL

Vericel Corporation

NASDAQ · USHealthcareBiotechnology
$45.88-1.63%

Price as of Jul 20, 2026

VCEL capital

Vericel Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.27x
Net debt / equity
-0.04x
Debt / assets
0.19x
Debt / EBITDA
2.68x
Net debt / EBITDA
-0.42x

Liquidity & coverage

Current ratio
5.18x
Quick ratio
4.79x
Cash ratio
3.08x
Interest coverage
24.76x
EBITDA / interest
55.35x
Working capital
$196.9M

Cash & dividend

FCF / debt
0.61x
Cash flow / debt
0.65x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.